Galera Therapeutics Received A Notice Of Allowance For Its U.S Patent Application 17/378,852 Titled "Pentaaza Macrocyclic Ring Complexes Possessing Oral Bioavailability (To Reduce Oral Mucositis In Head-And-Neck Cancer Patients From Chemoradiation)"
Galera Therapeutics收到了批准其美国专利申请 17/378,852 的通知，该专利名为 “具有口服生物利用度的Pentaaza大环复合物（减少化疗引起的头颈癌患者的口腔粘膜炎）”